Much of our research continues to center around the
protein folding problem. Structural and kinetic
information on folding events and structural intermediates is
essential for understanding the mechanism of folding and
the interactions involved in directing the polypeptide
chain toward its native fold. We are using a variety of
experimental approaches to investigate the kinetics and
energetics of folding for several well-characterized
proteins, including cytochrome c, ubiquitin, and
staphylococcal nuclease, as well as natural and
engineered variants of these proteins. For the study
of protein structure and dynamics, we rely on
multidimensional nuclear magnetic
resonance (NMR) spectroscopy, often in conjunction with
hydrogen exchange methods. To monitor the kinetics of
folding or unfolding reactions, we use various optical
probes, such as absorbance, static and
time-resolved fluorescence, and circular dichroism,
coupled with rapid mixing techniques. For a more
detailed structural description of transient folding
intermediates, we rely on pulsed hydrogen
exchange methods. Finally, we often combine these
structural and kinetic methods with mutagenic
approaches to investigate the role of individual
residues and their interactions in stabilizing the
various conformational states that participate in folding.
Another area of interest concerns macromolecular interactions, especially those involved in the recognition of ligand proteins and peptides by antibodies and other proteins. This work again makes extensive use of hydrogen exchange and NMR techniques. Other studies aimed at understanding protein function and molecular recognition on a detailed structural level also rely on modern multidimensional NMR methods.
Many small proteins can fold into their unique native structures with remarkable speed and efficiency. It has long been realized that the conformational space accessible to an unfolded polypeptide chain is much too vast for a protein to find the native state within such a short time by a random search mechanism. Thus, the prevalent opinion for many years has been that partially folded intermediates are formed at an early stage, limiting the conformational search by directing the polypeptide chain along a productive route toward the native state.
The kinetic importance of folding intermediates has recently been challenged by the observation that some small, single-domain proteins can fold rapidly in an apparent two-state reaction without evidence of structural intermediates. Moreover, there have been theoretical and experimental indications that proteins can encounter misfolded states with non-native conformation. It is unlikely that these observations are general, since there is little evidence for conformationally misfolded states in simple globular proteins. Partially folded kinetic intermediates have, in fact, been observed for many proteins, including those studied by our group. Early intermediates that have been characterized by NMR and hydrogen exchange methods generally show predominantly native-like structural elements, indicating that they are productive intermediates along a direct path toward the native state (1).
Our folding studies on a set of model proteins with diverse structural properties, including mammalian and bacterial cytochromes c, ubiquitin, and staphylococcal nuclease are beginning to reveal some common features. In each case, we find clear evidence for the rapid formation (within a few milliseconds) of folding intermediates with some common structural properties: they are compact states with extensive secondary structure and some critical native-like tertiary contacts, but they lack stable hydrogen bonds and have a loosely packed hydrophobic core. These properties resemble those of the partially folded equilibrium forms (molten globules) found for many proteins under mildly denaturing conditions. For all of the proteins studied in our laboratory, the kinetics of folding and unfolding is consistent with a kinetic mechanism with at least one sequential intermediate that is in rapid equilibrium with unfolded molecules and precedes the rate-limiting step in forming the native structure. Our observations support the notion that condensation of the polypeptide chain at an early stage of folding into a compact, yet dynamic, state with some key attributes of the native structure is essential for rapid and efficient protein folding.
Ubiquitin, a 76-residue protein with a
mixed
-sheet and an
-helix (Figure 1), is
ideal for investigating the intrinsic structural
determinants of protein folding.

FIGURE 1. Ribbon diagram of the F45W variant of
ubiquitin (4) illustrating the hydrophobic core
surrounded by the
-helix (residues 23-34) and the
mixed 5-strand
-sheet. The side chains of Val26
and nearby core resides are shown in ball-and-stick
representation. Also shown is the engineered Trp45
side chain, which serves as a fluorescence probe.
-helix
at its interface with the
-sheet and
is among the most deeply buried residues of
ubiquitin (Figure 1). Substitution by a larger
side chain (Leu or Ile) has little effect on the
stability of the native state against chemical
denaturation. The denaturant-dependence of
folding and unfolding kinetics for WT*
ubiquitin and these stable variants (V26I and
V26L) can be described quantitatively by the
following three-state mechanism:
I
N (Scheme
1),where U represents the ensemble of unfolded conformations, the intermediate I represents an ensemble of compact conformations with native-like fluorescence properties, and N is the native state. The intermediate I accumulates under certain stable refolding conditions (low denaturant concentration at room temperature, but not at 8° C) and is in rapid equilibrium with U. Kinetic analysis shows that a denaturant-independent process that limits the rate of folding at low denaturant concentrations reflects the rate-determining conversion of the intermediate into the native state. In terms of its response to mutations and solvent additives, the intermediate resembles the transition state for folding between I and N. The steep decrease in the overall rate of folding observed with increasing denaturant concentration for all ubiquitin variants, as well as most other proteins studied, is attributed to the diminishing population of the intermediate as its structure is destabilized by addition of denaturant.
In contrast to the stable variants, V26L and V26I, the V26A and V26G mutations destabilize not only the native state (by 3.3 and 6.3 kcal/mol, respectively), but also the kinetic intermediate (by 2.2 and 4.3 kcal/mol, respectively). Thus, parts of the hydrophobic core, including the regions around residue 26 and the fluorescence probe Trp45, are already consolidated in the intermediate and the subsequent transition state, although not as tightly packed as in the native structure. The kinetic behavior of V26A and V26G is that of an apparent two-state reaction, even in the absence of denaturant. However, the intermediate reappears for V26A on addition of a stabilizing salt (sodium sulfate), demonstrating that the mutation does not prevent formation of the intermediate, but simply destabilizes it. All observations can be modeled quantitatively with a sequential three-state mechanism (Scheme 1). For the stable variants at low denaturant concentrations, the free energy of I lies between U and N, so that I accumulates as a kinetic intermediate (Figure 2). On the other hand, disruptive mutations and/or addition of denaturants raise the free energy of I above that of U, so that it no longer accumulates as a detectable intermediate, resulting in an apparent two-state folding process with slower rates.

FIGURE 2. Free energy diagrams derived from three-state analysis of the kinetics of ubiquitin folding and unfolding (2), illustrating the effects of solvent conditions (Panel A) and mutation of Val26 to Ala (Panel B) on the relative free energies of the three conformational states, U, I and N.
We also considered an alternative folding mechanism in which I is a non-productive intermediate off the direct path between U and N:
U
N (Scheme 2).Although formal kinetic analysis cannot distinguish between these alternative models, the sequential mechanism (Scheme 1) requires fewer assumptions to explain the data and is physically more plausible. For example, Scheme 2 predicts that the overall rate of folding should increase when I is destabilized, in contrast to the behavior observed for ubiquitin and other proteins. To fit the data with Scheme 2 requires a large compensating increase in the free energy of the transition state between U and N, while Scheme 1 provides a more straightforward explanation of the observed kinetics in terms of the population of a structural intermediate. Thus, our analysis argues in favor of a protein folding mechanism with productive intermediates, which serve an essential role at early stages of folding in directing the protein toward the native conformation. The model also predicts that proteins showing apparent two-state kinetics may exhibit well-populated kinetic intermediates under sufficiently stabilizing conditions, as we found for the V26A variant of ubiquitin in the presence of a stabilizing salt.
Aside from a handful of functionally
important residues, including a Cys-X-X-Cys-His
motif near the N-terminus and a
methionine toward the C-terminus involved in heme
attachment and ligation, the prokaryotic
cytochrome c2 from
Rhodobacter capsulatus has little
sequence homology with the mitochondrial
cytochromes c. Nevertheless, they exhibit some
striking structural similarities, including two
-helices
near opposite ends of the polypeptide chain that
are tightly packed against each
other in a perpendicular arrangement. Since
formation and association of the N- and
C-terminal helices is a critical early event in the
folding of horse cytochrome c, it is possible that
constraints imposed by the mechanism of
folding are responsible for the conservation of this
structural motif. Another attractive feature of
cytochrome c2 is that the axial heme ligands,
His17 and Met96, are the only histidine and
methionine residues in the protein, unlike
horse cytochrome c, which has additional
histidines and methionines that complicate the
folding process by forming non-native heme
ligands. It also features a single tryptophan
residue in close proximity to the heme (analogous
to horse cytochrome c) that serves as a
convenient fluorescence probe for monitoring the
folding transition.
The kinetics of folding and unfolding of cytochrome c2 was measured as a function of denaturant concentration, both in the presence and absence of sodium sulfate, which is known to stabilize compact protein conformations (cf. ref. 2). The results are consistent with the following four-state mechanism:
I*
N*
NM (Scheme 3),where the asterisk indicates states with only
one axial ligand (His17) and a vacant sixth iron
coordination site, and NM represents the native
state with two axial ligands (His17 and Met96).
I* is a compact intermediate with quenched
tryptophan fluorescence, and N* is an almost
completely folded state lacking the native
Met96-iron bond. I* is well-populated at low
denaturant concentrations, where it gives rise
to a major burst phase (fluorescence decrease
during the mixing dead time), and the folding
rate approaches a denaturant-independent
value. As in the case of ubiquitin (2), this
kinetic behavior is explained by a sequential
intermediate in rapid equilibrium with U*,
followed by a denaturant-independent
rate-limiting step (I* --> N*).
The U*
I*
equilibrium depends strongly on solvent
conditions: addition of denaturant shifts it toward
U*, so that I* is no longer populated in the
unfolding transition region, while addition of
sodium sulfate shifts it toward the right,
stabilizing I*. In order to explain the unusual
denaturant-dependence of the rate of unfolding
observed for this and other cytochromes c, it is
necessary to introduce a second intermediate,
N*, which is encountered in the unfolding
process. Above the midpoint of the guanidine-induced
unfolding transition, the unfolding
reaction is limited by the N* -->; I* step,
whereas the NM --> N* step becomes
rate-limiting at very high denaturant concentration. As
in the case of horse cytochrome c (3), we
attribute this effect to the dissociation of the
methionine ligand from the heme, which
precedes the main structural unfolding transition.
In order to understand the structural
and energetic basis of packing interactions
between the N- and C-terminal
-helices of
horse cytochrome c and their role in folding,
we characterized a series of variants in which
an important contact residue, Leu94, was
replaced by Ile, Val or Ala (3). Last year, we
reported preliminary results on the
thermodynamic and kinetic consequences of these
amino acid changes. We found that the
transient population of a previously characterized
folding intermediate, INC, was especially
sensitive to mutations at the helix-helix interface,
confirming that it contains tightly interacting
N- and C-terminal helices. We have extended
these studies by measuring the effect of
mutations on the population of an early compact
folding intermediate, IC, which precedes INC.
Both the population of IC and the stability of
the native structure are quite insensitive to
conservative substitutions at position 94 (L94I
and L94V), while the INC intermediate is
strongly destabilized by these mutations.
Replacement of Leu94 with the smaller Ala
destabilizes all three states and reduces the
population of INC to negligible levels. These
observations show that the initial compaction
of the polypeptide chain is driven by relatively
nonspecific hydrophobic interactions, while
the stabilization of the subsequent INC
intermediate relies on more specific packing
interactions of hydrophobic side chains at the
helix-helix interface.
Papers in press at time of previous report:
ZHANG, Y.Z., PATERSON,Y., RODER, H. Rapid amide proton exchange rates in peptides and proteins measured by solvent quenching and 2D NMR. Protein Sci. 4: 804-814, 1995.
b A.K. Bhuyan: National Center for Biological Sciences, TIFR, Bangalore, 560012, India
c S. Khorasanizadeh: Chemistry Department, University of Maryland, Baltimore, MD 21228
d P.B. Laub: Department of Medical Oncology, Fox Chase Cancer Center
e I.D. Peters: Hawaii Biotechnology Group, Inc., Aiea, HI 96701
f N.E. MacKenzie: College of Pharmacy, University of Arizona, Tucson, AZ 85721
g F. Sherman: University of Rochester School of Medicine and Dentistry, Rochester, NY 14642